Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States Adults

Keywords

Medicine, Hazard ratio, Metabolic syndrome, Diabetes mellitus, Proportional hazards model

References

• The significance of impaired fasting glucose versus impaired glucose tolerance: importance of insulin secretion and resistance.Gian Piero Carnevale Schianca, Antonello Rossi, Pier Paolo Sainaghi — 2003
• Cardiovascular morbidity and mortality associated with the metabolic syndrome.Bo Isomaa, Peter Almgren, Tiinamaija Tuomi — 2001
• Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines.Ian Janssen, Peter T. Katzmarzyk, Robert Ross — 2002
• The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.Yong-Woo Park, Shankuan Zhu, Latha Palaniappan — 2003
• Fasting hyperinsulinism, insulin resistance syndrome, and coronary artery disease in men and women.B Solymoss, Michel Marcil, Mostafa Chaour — 1995
• Impact of Diabetes on Mortality After the First Myocardial InfarctionHeikki Miettinen, Seppo Lehto, Veikko Salomaa — 1998
• Preventing coronary events by optimal control of blood pressure and lipids in patients with the metabolic syndrome.Nathan D. Wong, Jose R. Pio, Stanley S. Franklin — 2003
• The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men.Eunyoung Cho, Eric B. Rimm, Meir J. Stampfer — 2002
• The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.Hanna‐Maaria Lakka — 2002
• Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.Earl S. Ford, Wayne H. Giles, William H. Dietz — 2002
• Banting lecture 1988. Role of insulin resistance in human disease.Gerald M. Reaven — 1988
• Association of the Metabolic Syndrome With History of Myocardial Infarction and Stroke in the Third National Health and Nutrition Examination SurveyJohn K. Ninomiya, Gilbert L’Italien, Michael H. Criqui — 2004
• Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study.M Hanefeld, Carsta Koehler, Katja Fuecker — 2003
• The metabolic syndrome, diabetes, and subclinical atherosclerosis assessed by coronary calcium.Nathan D. Wong, Maria Sciammarella, Donna M. Polk — 2003
• Syndrome X and mortality: a population-based study. Risk Factor and Life Expectancy Research Group.Maurizio Trevisan, J Liu, Fadlalla Bahsas Bahsas — 1998
• Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)Scott M. Grundy — 1993
• Hyperinsulinemia and cardiovascular disease in elderly men: the Honolulu Heart Program.Cecil M. Burchfiel, Dan S. Sharp, J. David Curb — 1998
• Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO ConsultationK. G. M. M. Alberti, Paul Zimmet, WHO Consultation — 1998
• Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.Peter Gæde, Pernille Vedel, Nicolai Balle Larsen — 2003
• Age and the burden of death attributable to diabetes in the United States.Sharon Saydah — 2002

Cited by

• Effects of lifestyle interventions on inflammatory markers in the metabolic syndromeKristen M. Beavers — 2011
• The relative risk of cardiovascular death among racial and ethnic minorities with metabolic syndrome: data from the NHANES-II mortality follow-up.David Martins, Naureen Tareen, Godwin Ogedegbe — 2008
• Identifying risk of type 2 diabetes : epidemiologic perspectives from biomarkers to lifestyleMargareta Norberg — 2006
• Aldosteron und HypertonieOliver Vonend, Ivo Quack, Lars Christian Rump — 2010
• Ion channels as effectors in carbon monoxide signalingZohreh Setayeshgar — 2009
• Gallstones associated with nonalcoholic steatohepatitis (NASH) and metabolic syndrome.Oktay Yener, Fikret Aksoy, Mustafa Demır — 2010
• The role of flavor-flavor conditioning and sensory-based, vegetable-themed education in increasing vegetable consumption in elementary school-aged childrenMeagan Roxanne Latimer — 2009
• Enhancing Diabetic Care in the Community in Malaysia: Need for a Paradigm ShiftLekhraj Rampal Gyanchand Rampal, Yik Yee Loong, Azhar Md. Zain — 2010
• Metabolic syndrome: pathogenesis, medical care and dental implications.Arthur H. Friedlander, Jane Weinreb, Ida K Friedlander — 2007
• Cardiac Anesthesia and Surgery in Geriatric Patients: Epidemiology, Current Surgical Outcomes, and Future DirectionsJavier G. Castillo, George Silvay, Joanna Chikwe — 2009
• Measurement of the coronary flow velocity reserve in patients with non-alcoholic fatty liver disease.Binnur Pınarbaşı, Kadir Demır, Hüseyin Oflaz — 2012
• Dairy fat biomarkers and cardiometabolic healthJonas Ohlsson — 2014
• Coexistence of anaemia and the metabolic syndrome in adults in Jiangsu, China.Zumin Shi, Xiao‐shu Hu, Baojun Yuan — 2008
• Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017Makoto Kinoshita, Koutaro Yokote, Hidenori Arai — 2018
• The Effects of Low-Fat Diet and Exercise on C-Reactive Protein and Metabolic Syndrome: Findings from a Randomized Controlled TrialSarah M. Camhi — 2008
• Relationship of C-reactive protein, metabolic syndrome and diabetes mellitus: potential role of statins.David T. Nash — 2005
• Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies.Apoor S. Gami, Brandi J. Witt, Daniel E. Howard — 2007
• Metabolic syndrome and risk of acute myocardial infarction a case-control study of 26,903 subjects from 52 countries.Andrew Mente, Salim Yusuf, Shofiqul Islam — 2010
• Metabolic syndrome and urologic diseases.Ilya Gorbachinsky, Haluk Akpınar, Dean G. Assimos — 2010
• Effect of renin angiotensin system inhibition on cardiovascular sequelae in elderly hypertensive patients with insulin resistanceHala H. Zreikat — 2009

Related papers

• Is a single definition of the metabolic syndrome appropriate?--A comparative study of the USA and Asia.Anushka Patel, Kuo‐Chin Huang, Edward Janus — 2006
• Prevalence of metabolic syndrome in adolescents aged 10-18 years in Jammu, J and KNarinder Singh, Ravi Kumar Parihar, Ghanshyam Saini — 2013
• Associated Factors Of Metabolic Syndrome And The Role Of Oral Health Among 50 And Older Adults: from the 6th KNHANESMoon-Hee Kwon — 2021
• Uric acid and mortality from all-causes and cardiovascular disease among adults with and without diagnosed diabetes: findings from the National Health and Nutrition Examination Survey III Linked Mortality Study.Earl S. Ford — 2011
• Adolescent lipoprotein classifications according to National Health and Nutrition Examination Survey (NHANES) vs. National Cholesterol Education Program (NCEP) for predicting abnormal lipid levels in adulthood in a Middle East populationMasumeh Hatami, Maryam Tohidi, Reza Mohebi — 2012
• Prevalence of Metabolic Syndrome According to Adult Treatment Panel III and International Diabetes Federation Criteria: A Population-Based StudyAbdülbari Bener, Mahmoud Zirie, Manal Musallam — 2009
• Comparison of three different definitions for the metabolic syndrome in non-diabetic Europeans:THE DECODE STUDY GROUP, Qing Qiao — 2005
• A Proposal for the Cutoff Point of Waist Circumference for the Diagnosis of Metabolic Syndrome in the Japanese PopulationKazuhiro Hara — 2006
• Psoriasis and Metabolic SyndromeEldina Malkic Salihbegovic, Nermina Hadžigrahić, Amra Čičkušić — 2015